Skip to content
10-K

Annual Report

CHECKPOINT THERAPEUTICS, INC.

0001410578-25-000528

← back to feed
Filed
Mar 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2024 · Dec 31, 2024 39.67M sh
Shares Diluted FY 2024 · Dec 31, 2023 18.74M sh
Shares Outstanding FY 2024 · Dec 31, 2024 53.64M sh
Shares Outstanding FY 2024 · Dec 31, 2023 27.04M sh
Operating Cash Flow FY 2024 · Dec 31, 2024 −$31.1M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$47.59M
Cash And Equivalents FY 2024 · Dec 31, 2024 $6.6M
Cash And Equivalents FY 2024 · Dec 31, 2023 $4.93M
Stockholders Equity FY 2024 · Dec 31, 2024 −$12.63M
Stockholders Equity FY 2024 · Dec 31, 2023 −$13.05M
Stockholders Equity FY 2024 · Dec 31, 2022 −$19.48M
Current Liabilities FY 2024 · Dec 31, 2024 $20.1M
Current Liabilities FY 2024 · Dec 31, 2023 $18.43M
Total Liabilities FY 2024 · Dec 31, 2024 $20.1M
Total Liabilities FY 2024 · Dec 31, 2023 $18.43M
Current Assets FY 2024 · Dec 31, 2024 $7.47M
Current Assets FY 2024 · Dec 31, 2023 $5.38M
Total Assets FY 2024 · Dec 31, 2024 $7.47M
Total Assets FY 2024 · Dec 31, 2023 $5.38M
Eps Diluted FY 2024 · Dec 31, 2024 −$1.42
Eps Diluted FY 2024 · Dec 31, 2023 −$3.17
Eps Basic FY 2024 · Dec 31, 2024 −$1.42
Eps Basic FY 2024 · Dec 31, 2023 −$3.17
Sga Expense FY 2024 · Dec 31, 2024 $20.06M
Sga Expense FY 2024 · Dec 31, 2023 $8.69M
Rd Expense FY 2024 · Dec 31, 2024 $36.15M
Rd Expense FY 2024 · Dec 31, 2023 $43.57M
Net Income FY 2024 · Dec 31, 2024 −$56.24M
Net Income FY 2024 · Dec 31, 2023 −$51.85M
Operating Income FY 2024 · Dec 31, 2024 −$56.17M
Operating Income FY 2024 · Dec 31, 2023 −$52.15M
Revenue FY 2024 · Dec 31, 2024 $41K
Revenue FY 2024 · Dec 31, 2023 $103K